These combined reports indicated that the abnormal change of ErbB4 may be involved in the progression of AD pathology and NRG1 can undertake neuroprotective actions against Swedish amyloid precursor protein-induced neurotoxicity (Woo et al., 2011; Table 2). This evidence concerns the gene ERBB4 and Alzheimer disease.